Resultats de la cerca - Jun Aoki

  • Mostrar 1 - 8 resultats de 8
Refinar resultats
  1. 1
    Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins

    Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins per Kei Sato, Jun Aoki, Naoko Misawa, Eriko Daikoku, Kouichi Sano, Yuetsu Tanaka, Yoshio Koyanagi

    Publicat 2007
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    A CD63 Mutant Inhibits T‐cell Tropic Human Immunodeficiency Virus Type 1 Entry by Disrupting CXCR4 Trafficking to the Plasma Membrane

    A CD63 Mutant Inhibits T‐cell Tropic Human Immunodeficiency Virus Type 1 Entry by Disrupting CXCR4 Trafficking to the Plasma Membrane per Takeshi Yoshida, Yuji Kawano, Kei Sato, Yoshinori Ando, Jun Aoki, Yoshiharu Miura, Jun Komano, Yuetsu Tanaka, Yoshio Koyanagi

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Post‐transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high‐risk acute myeloid leukaemia

    Post‐transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high‐risk acute myeloid leukaemia per Gaku Oshikawa, Kazuhiko Kakihana, Makoto Saito, Jun Aoki, Yuho Najima, Takeshi Kobayashi, Noriko Doki, Hisashi Sakamaki, Kazuteru Ohashi

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  4. 4
    Inhibition of Tumor Growth and Metastasis by Depletion of Vesicular Sorting Protein Hrs: Its Regulatory Role on E-Cadherin and β-Catenin

    Inhibition of Tumor Growth and Metastasis by Depletion of Vesicular Sorting Protein Hrs: Its Regulatory Role on E-Cadherin and β-Catenin per Masafumi Toyoshima, Nobuyuki Tanaka, Jun Aoki, Yoshinori Tanaka, Kazuko Murata, Masanao Kyuuma, Kobayashi Hideyuki, Naoto Ishii, Nobuo Yaegashi, Kazuo Sugamura

    Publicat 2007
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR

    Comparable outcomes between autologous and allogeneic transplant for adult acute myeloid leukemia in first CR per Motonori Mizutani, Masahiko Hara, Hiroyuki Fujita, Jun Aoki, Heiwa Kanamori, Kazuteru Ohashi, Kensuke Usuki, Takahiro Fukuda, Takaaki Chou, Junji Tanaka, Yoshiko Atsuta, Akiyoshi Takami

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia

    Impact of age on outcomes of allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in elderly patients with acute myeloid leukemia per Jun Aoki, Heiwa Kanamori, Masatsugu Tanaka, Satoshi Yamasaki, Takahiro Fukuda, Hiroyasu Ogawa, Koji Iwato, Kazuteru Ohashi, Hirokazu Okumura, Makoto Onizuka, Yoshitomo Maesako, Takanori Teshima, Naoki Kobayashi, Yasuo Morishima, Makoto Hirokawa, Yoshiko Atsuta, Shingo Yano, Akiyoshi Takami

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data?

    Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data? per Kiyomi Ito, Kōji Chiba, Masato Horikawa, Michi Ishigami, Naomi Mizuno, Jun Aoki, Yasumasa Gotoh, Takafumi Iwatsubo, Shin-ichi Kanamitsu, Motohiro Kato, Iichiro Kawahara, Kayoko Niinuma, Akiko Nishino, Norihito Sato, Yuko Tsukamoto, Kaoru Ueda, Tomoo Itoh, Yuichi Sugiyama

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial

    Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial per Kazunori Murai, Hiroshi Ureshino, Takashi Kumagai, Hideo Tanaka, Kaichi Nishiwaki, Satoshi Wakita, Koiti Inokuchi, Toshihiro Fukushima, Chikashi Yoshida, Nobuhiko Uoshima, Toru Kiguchi, Masayuki Mita, Jun Aoki, Satoshi Kimura, Kaori Karimata, Kensuke Usuki, Joji Shimono, Yoshiaki Chinen, Junya Kuroda, Yasufumi Matsuda, Kensuke Nakao, Takaaki Ono, Katsumichi Fujimaki, Hirohiko Shibayama, Chisaki Mizumoto, Tomoharu Takeoka, Katsuhiro Io, Takeshi Kondo, Masatomo Miura, Yousuke Minami, Takayuki Ikezoe, Jun Imagawa, Ayako Takamori, Atsushi Kawaguchi, Junichi Sakamoto, Shinya Kimura

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: